Skip Nav Destination
Issues
15 November 2011
-
Cover Image
Cover Image
- PDF Icon PDF LinkTable of Contents
ISSN 1078-0432
EISSN 1557-3265
Highlights
CCR Translations
CCR Drug Updates
Molecular Pathways
Perspective
Reviews
Human Cancer Biology
Novel Chromosomal Rearrangements and Break Points at the t(6;9) in Salivary Adenoid Cystic Carcinoma: Association with MYB–NFIB Chimeric Fusion, MYB Expression, and Clinical Outcome
Yoshitsugu Mitani; Pulivarthi H. Rao; P. Andrew Futreal; Dianna B. Roberts; Philip J. Stephens; Yi-Jue Zhao; Li Zhang; Mutsumi Mitani; Randal S. Weber; Scott M. Lippman; Carlos Caulin; Adel K. El-Naggar
Two Distinct Routes to Oral Cancer Differing in Genome Instability and Risk for Cervical Node Metastasis
Aditi Bhattacharya; Ritu Roy; Antoine M. Snijders; Gregory Hamilton; Jesse Paquette; Taku Tokuyasu; Henrik Bengtsson; Richard C. K. Jordan; Adam B. Olshen; Daniel Pinkel; Brian L. Schmidt; Donna G. Albertson
Cancer Therapy: Preclinical
Improving T-cell Therapy for Relapsed EBV-Negative Hodgkin Lymphoma by Targeting Upregulated MAGE-A4
Conrad R. Cruz; Ulrike Gerdemann; Ann M. Leen; Jessica A. Shafer; Stephanie Ku; Benjamin Tzou; Terzah M. Horton; Andrea Sheehan; Amanda Copeland; Anas Younes; Cliona M. Rooney; Helen E. Heslop; Catherine M. Bollard
A Novel Kinase Inhibitor, INCB28060, Blocks c-MET–Dependent Signaling, Neoplastic Activities, and Cross-Talk with EGFR and HER-3
Xiangdong Liu; Qian Wang; Gengjie Yang; Cindy Marando; Holly K. Koblish; Leslie M. Hall; Jordan S. Fridman; Elham Behshad; Richard Wynn; Yu Li; Jason Boer; Sharon Diamond; Chunhong He; Meizhong Xu; Jincong Zhuo; Wenqing Yao; Robert C. Newton; Peggy A. Scherle
Imaging, Diagnosis, Prognosis
A Hypermethylated Phenotype Is a Better Predictor of Survival than MGMT Methylation in Anaplastic Oligodendroglial Brain Tumors: A Report from EORTC Study 26951
Martin J. van den Bent; Lonneke A. Gravendeel; Thierry Gorlia; Johan M. Kros; Lariesa Lapre; Pieter Wesseling; Johannes L. Teepen; Ahmed Idbaih; Marc Sanson; Peter A.E. Sillevis Smitt; Pim J. French
Cancer Therapy: Clinical
Biologic and Clinical Activity of Tivozanib (AV-951, KRN-951), a Selective Inhibitor of VEGF Receptor-1, -2, and -3 Tyrosine Kinases, in a 4-Week-On, 2-Week-Off Schedule in Patients with Advanced Solid Tumors
Ferry A.L.M. Eskens; Maja J.A. de Jonge; Pankaj Bhargava; Toshiyuki Isoe; Monette M. Cotreau; Brooke Esteves; Kunihiko Hayashi; Herman Burger; Maarten Thomeer; Leni van Doorn; Jaap Verweij
A Pilot Study of MUC-1/CEA/TRICOM Poxviral-Based Vaccine in Patients with Metastatic Breast and Ovarian Cancer
Mahsa Mohebtash; Kwong-Yok Tsang; Ravi A. Madan; Ngar-Yee Huen; Diane J. Poole; Caroline Jochems; Jacquin Jones; Theresa Ferrara; Christopher R. Heery; Philip M. Arlen; Seth M. Steinberg; Mary Pazdur; Myrna Rauckhorst; Elizabeth C. Jones; William L. Dahut; Jeffrey Schlom; James L. Gulley
GLIPR1 Tumor Suppressor Gene Expressed by Adenoviral Vector as Neoadjuvant Intraprostatic Injection for Localized Intermediate or High-Risk Prostate Cancer Preceding Radical Prostatectomy
Guru Sonpavde; Timothy C. Thompson; Rajul K. Jain; Gustavo E. Ayala; Shinji Kurosaka; Kohei Edamura; Ken-ichi Tabata; Chengzhen Ren; Alexei A. Goltsov; Martha P. Mims; Teresa G. Hayes; Michael M. Ittmann; Thomas M. Wheeler; Adrian Gee; Brian J. Miles; Dov Kadmon
Predictive Biomarkers and Personalized Medicine
Cytokeratin-19 and Mammaglobin Gene Expression in Circulating Tumor Cells from Metastatic Breast Cancer Patients Enrolled in North Central Cancer Treatment Group Trials, N0234/336/436/437
Monica M. Reinholz; Kathleen A. Kitzmann; Kathleen Tenner; David Hillman; Amylou C. Dueck; Timothy J. Hobday; Donald W. Northfelt; Alvaro Moreno-Aspitia; Vivek Roy; Betsy LaPlant; Jake B. Allred; Philip J. Stella; Wilma L. Lingle; Edith A. Perez
Relationship between Quantitative GRB7 RNA Expression and Recurrence after Adjuvant Anthracycline Chemotherapy in Triple-Negative Breast Cancer
Joseph A. Sparano; Lori J. Goldstein; Barrett H. Childs; Steven Shak; Diana Brassard; Sunil Badve; Frederick L. Baehner; Roberto Bugarini; Steve Rowley; Edith A. Perez; Lawrence N. Shulman; Silvana Martino; Nancy E. Davidson; Paraic A. Kenny; George W. Sledge, Jr; Robert Gray
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.